Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...
As legal battles over the federal funding freeze and indirect cost payments from NIH play out in court, cancer research is being disrupted.
New findings question assumptions of cancer formation in individuals with the cancer-predisposition syndrome, ...
Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...
Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results